Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study

DI-ALH is often under-recognised in clinical practice, leading to unnecessary long-term immunosuppression. A causal relationship between drugs and AIH, along with an attempt to withdraw treatment and long-term follow-up, is essential to prevent overtreatment-associated risks.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-08-26
DOI
https://doi.org/10.1111/apt.70353
Citations
4
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
5.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study

Beatriz Muñoz, Vanesa Bernal Monterde, Álvaro Díaz‐González, Sara Lorente et al.
4 citations
Alimentary Pharmacology & Therapeutics
Liver Diseases and Immunity
5.29
article

Unveiling Drug‐Induced Autoimmune‐Like Hepatitis in Autoimmune Hepatitis Patients: A Multicenter Retrospective Study

Beatriz Muñoz, Vanesa Bernal Monterde, Álvaro Díaz‐González, Sara Lorente, Ignasi Olivas, Ana Pascual‐Dapena, Raúl J. Andrade, Helena Hernández‐Évole, Sergio Rodríguez‐Tajes, Xavier Forns, Inmaculada Castelló, Mar Riveiro‐Barciela, Ana Arencibía, Marı́a Barrio, Isabel Conde, Anna Casas Aguilar, Anna Pocurull, María‐Carlota Londoño, Pinelopi Arvaniti, Diana Paola Bocanegra Horta, Paula Esteban García, JohnA.J. Barbara, Indhira Pérez‐Medrano, Ángel Marcos, Elena Góméz, Patricia Cuenca, Miguel Jiménez
article en
4 citations

Abstract

DI-ALH is often under-recognised in clinical practice, leading to unnecessary long-term immunosuppression. A causal relationship between drugs and AIH, along with an attempt to withdraw treatment and long-term follow-up, is essential to prevent overtreatment-associated risks.

Alimentary Pharmacology & TherapeuticsVol. 63(3)
Hebron University (PS), Instituto de Salud Carlos III (ES), Hospital General Universitario Gregorio Marañón (ES), Hospital Clínico San Carlos (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario Nuestra Señora de Candelaria (ES), University Hospital Mútua de Terrassa (ES), Marqués de Valdecilla University Hospital (ES), Hospital Universitario 12 De Octubre (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Instituto de Investigación Marqués de Valdecilla (ES), Hospital Clínic de Barcelona (ES), Vall d'Hebron Hospital Universitari (ES), Hospital General Universitario De Valencia (ES), Mútua Terrassa (ES), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES), Complejo Hospitalario de Pontevedra (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Hospital Universitario Ramón y Cajal (ES), Instituto de Investigación Biomédica de Málaga (ES)
Openalex Percentile: Top 4%
Liver Diseases and Immunity
5.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.